A detailed history of Israel Englander (Millennium Management LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 373,757 shares of PLX stock, worth $631,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
373,757
Previous 811,160 53.92%
Holding current value
$631,649
Previous $949,000 59.85%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.9 - $1.17 $393,662 - $511,761
-437,403 Reduced 53.92%
373,757 $381,000
Q2 2024

Aug 14, 2024

BUY
$1.1 - $1.32 $880,743 - $1.06 Million
800,676 Added 7637.12%
811,160 $949,000
Q1 2024

May 15, 2024

BUY
$1.22 - $1.82 $12,790 - $19,080
10,484 New
10,484 $13,000
Q2 2023

Aug 14, 2023

SELL
$2.0 - $3.36 $130,932 - $219,965
-65,466 Reduced 75.51%
21,232 $42,000
Q1 2023

May 15, 2023

BUY
$1.37 - $2.16 $118,776 - $187,267
86,698 New
86,698 $182,000

Others Institutions Holding PLX

About Protalix BioTherapeutics, Inc.


  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $84.1M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.